Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders??? Equity - Schedule of Stock Option Activity (Details)

v3.26.1
Shareholders’ Equity - Schedule of Stock Option Activity (Details) - Stock Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Stock Option Activity [Line Items]        
Outstanding share options, ending balance 6,052,214 4,083,497 4,590,375 5,057,255
Weighted-average exercise price, ending balance (in Dollars per share) $ 4.166 $ 4.38 $ 4.62 $ 4.543
Weighted average remaining contractual life (years), ending balance 5 years 6 months 25 days 5 years 6 months 10 days 5 years 10 months 13 days 5 years 7 months 28 days
Aggregate intrinsic value, ending balance (in Dollars) $ 7,761,705 $ 326,730 $ 1,364,975 $ 2,352,517
Exercisable, Outstanding share options   3,577,070    
Exercisable, Weighted-average exercise price (in Dollars per share)   $ 4.71    
Exercisable, Weighted average remaining contractual life (years)   5 years 14 days    
Exercisable, Aggregate intrinsic value (in Dollars)   $ 326,730    
Options available for future grants, Outstanding share options   1,976,527    
Granted, Outstanding share options   360,000 80,000 430,874
Granted, Weighted-average exercise price (in Dollars per share)     $ 1.91 $ 2.728
Forfeited, Outstanding share options   (471,914) (291,124) (351,671)
Forfeited, Weighted-average exercise price (in Dollars per share)     $ 6.08 $ 7.767
Exercised, Outstanding share options   (394,964) (255,756) (1,074,162)
Exercised, Weighted-average exercise price (in Dollars per share)     $ 0.81 $ 0.654